75 FR 177 pg. 55810 - Withdrawal of Approval of New Animal Drug Applications; Chloramphenicol, Lincomycin, Pyrantel Tartrate, and Tylosin Phosphate and Sulfamethazine

Type: NOTICEVolume: 75Number: 177Page: 55810
Docket number: [Docket No. FDA-2010-N-0425]
FR document: [FR Doc. 2010-22809 Filed 9-13-10; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version:  PDF Version

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0425]

Withdrawal of Approval of New Animal Drug Applications; Chloramphenicol, Lincomycin, Pyrantel Tartrate, and Tylosin Phosphate and Sulfamethazine

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADAs). In a final rule published elsewhere in this issue of the Federal Register , FDA is amending the regulations to remove portions reflecting approval of these NADAs.

DATES:

Withdrawal of approval is effective September 24, 2010.

FOR FURTHER INFORMATION CONTACT:

John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, email: john.bartkowiak@fda.hhs.gov .

SUPPLEMENTARY INFORMATION:

John J. Ferrante, 11 Fairway Lane, Trumbull, CT 06611; International Nutrition, Inc., 7706 "I" Plaza, Omaha, NE 68127; and Feed Service Co., Inc., 303 Lundin Blvd., P.O. Box 698, Mankato, MN 56001 have requested that FDA withdraw approval of the four NADAs listed in table 1 because they are no longer manufactured or marketed:

Sponsor NADA Number Product (Established Name of Drug) 21 CFR Cite (Sponsor's Drug Labeler Code)
John J. Ferrante, 11 Fairway Lane, Trumbull, CT 06611 NADA 65-137 AMPHICOL-V Capsules (chloramphenicol) § 520.390b (058034)
International Nutrition, Inc., 7706 "I" Plaza, Omaha, NE 68127 NADA 121-337 INI Swine Ban-Wormer B-9.6 BA. (pyrantel tartrate) § 558.485 (043733)
International Nutrition, Inc., 7706 "I" Plaza, Omaha, NE 68127 NADA 132-923 LINCO 8/LINCO 20 (lincomycin) § 558.325 (043733)
Feed Service Co., Inc., 303 Lundin Blvd., P.O. Box 698, Mankato, MN 56001 NADA 138-342 TYLAN 5 Sulfa-G Premix (tylosin and sulfamethazine) § 558.630 (030841)

Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with § 514.116 Notice of withdrawal of approval of application (21 CFR 514.116), notice is given that approval of NADAs 65-137, 121-337, 132-923, and 138-342, and all supplements and amendments thereto, is hereby withdrawn, effective September 24, 2010.

In a final rule published elsewhere in this issue of the Federal Register , FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs.

Dated: September 1, 2010.

Bernadette Dunham,

Director, Center for Veterinary Medicine.

[FR Doc. 2010-22809 Filed 9-13-10; 8:45 am]

BILLING CODE 4160-01-S